Thr55
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.6.0.4
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Thr55  -  p21Cip1 (human)

Site Information
RWNFDFVtEtPLEGD   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 1869957900

In vivo Characterization
Methods used to characterize site in vivo:
immunoassay ( 1 ) , immunoprecipitation ( 1 ) , microscopy-colocalization with upstream kinase ( 1 ) , mutation of modification site ( 1 ) , western blotting ( 1 )
Disease tissue studied:
obesity, hyperphagic ( 1 )
Relevant cell line - cell type - tissue:
'blood, serum' ( 1 ) , 293 (epithelial) ( 1 ) , 3T3-L1 (fibroblast) ( 1 ) , MEF (fibroblast) ( 1 )

Upstream Regulation
Putative in vivo kinases:
MELK (mouse) ( 1 )
Kinases, in vitro:
MELK (mouse) ( 1 )

Downstream Regulation
Effects of modification on p21Cip1:
activity, induced ( 1 ) , intracellular localization ( 1 ) , molecular association, regulation ( 1 ) , protein stabilization ( 1 )
Effects of modification on biological processes:
apoptosis, induced ( 1 ) , cell cycle regulation ( 1 ) , cell differentiation, inhibited ( 1 ) , cell growth, inhibited ( 1 ) , signaling pathway regulation ( 1 )
Induce interaction with:
CDK2 (human) ( 1 ) , CDK4 (human) ( 1 ) , PPAR-gamma (mouse) ( 1 )
Inhibit interaction with:
MDM2 (human) ( 1 )

References 

1

Seong HA, Ha H (2019) Thr55 phosphorylation of p21 by MPK38/MELK ameliorates defects in glucose, lipid, and energy metabolism in diet-induced obese mice. Cell Death Dis 10, 380
31097688   Curated Info

Developed with grants from  NIH Logo and literature mining with Linguamatics  I2E Logo Creative Commons License PhosphoSite, created by Cell Signaling Technology is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.

©2003-2019 Cell Signaling Technology, Inc.